Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 3
2013 1
2014 1
2018 1
2019 1
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Antibody response and soluble mediator profile in the first six months following acute SARS-CoV-2 infection.
Corsini CA, Filgueiras PS, Almeida NB, Miranda DA, Gomes SV, Lourenço AJ, Bicalho CM, Assis JV, Amorim RN, Silva RA, Vilela RV, Lima TM, Abreu DP, Alvim RG, Castilho LR, Martins-Filho OA, Otta DA, Grenfell RF. Corsini CA, et al. Among authors: assis jv. Sci Rep. 2023 Oct 30;13(1):18606. doi: 10.1038/s41598-023-43263-y. Sci Rep. 2023. PMID: 37903875 Free PMC article.
Booster dose of BNT162b2 in a CoronaVac primary vaccination protocol improves neutralization of SARS-CoV-2 Omicron variant.
Campos GRF, Almeida NBF, Filgueiras PS, Corsini CA, Gomes SVC, de Miranda DAP, de Assis JV, de Souza Silva TB, Alves PA, da Rocha Fernandes G, de Oliveira JG, Rahal P, Queiroz RFG, Nogueira ML. Campos GRF, et al. Among authors: de assis jv. medRxiv [Preprint]. 2022 Mar 25:2022.03.24.22272904. doi: 10.1101/2022.03.24.22272904. medRxiv. 2022. PMID: 35350193 Free PMC article. Updated. Preprint.
Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant.
Campos GRF, Almeida NBF, Filgueiras PS, Corsini CA, Gomes SVC, de Miranda DAP, de Assis JV, de Souza Silva TB, Alves PA, da Rocha Fernandes G, de Oliveira JG, Rahal P, Grenfell RFQ, Nogueira ML. Campos GRF, et al. Among authors: de assis jv. Commun Med (Lond). 2022 Jun 29;2:76. doi: 10.1038/s43856-022-00141-4. eCollection 2022. Commun Med (Lond). 2022. PMID: 35784447 Free PMC article.
Rapid antigen test as a tool for the identification of SARS-CoV-2 infection and its potential as a self-testing device.
Filgueiras PS, Corsini CA, Almeida NBF, Pedrosa MLC, Miranda DAP, Gomes SVC, Assis JV, Silva RA, Medeiros MIVARC, Lourenço AJ, Bicalho CMF, Vilela RVR, Jeremias WJ, Fernandes GDR, Queiroz RFGE. Filgueiras PS, et al. Among authors: assis jv. Rev Soc Bras Med Trop. 2023 May 22;56:e01672022. doi: 10.1590/0037-8682-0167-2022. eCollection 2023. Rev Soc Bras Med Trop. 2023. PMID: 37222349 Free PMC article.
An isoniazid analogue promotes Mycobacterium tuberculosis-nanoparticle interactions and enhances bacterial killing by macrophages.
de Faria TJ, Roman M, de Souza NM, De Vecchi R, de Assis JV, dos Santos AL, Bechtold IH, Winter N, Soares MJ, Silva LP, De Almeida MV, Báfica A. de Faria TJ, et al. Among authors: de assis jv. Antimicrob Agents Chemother. 2012 May;56(5):2259-67. doi: 10.1128/AAC.05993-11. Epub 2012 Feb 13. Antimicrob Agents Chemother. 2012. PMID: 22330919 Free PMC article.
Innovative methodology for point-of-care circulating cathodic antigen with rapid urine concentration for use in the field for detecting low Schistosoma mansoni infection and for control of cure with high accuracy.
Grenfell RFQ, Taboada D, Coutinho LA, Pedrosa MLC, Assis JV, Oliveira MSP, Cruz RR, Almeida A, Silva-Moraes V, Katz N, Coelho PMZ. Grenfell RFQ, et al. Among authors: assis jv. Trans R Soc Trop Med Hyg. 2018 Jan 1;112(1):1-7. doi: 10.1093/trstmh/try014. Trans R Soc Trop Med Hyg. 2018. PMID: 29522211
13 results